The COVID-19 outbreak and approaches to performing EEG in Europe
The COVID-19 outbreak and approaches to performing EEG in Europe
复制标题
DOI：
10.1684/epd.2020.1208
复制
发表时间：
2020-10-01
影响因子：
2.3
通讯作者：
Arzimanoglou, Alexis
中科院分区：
文献类型：
--
作者：
Krysl, David;Beniczky, Sandor;Arzimanoglou, Alexis
目标。冠状病毒SARS-CoV-2疾病（COVID-19）大流行影响了神经生理学诊断方法（包括EEG）的可用性和性能。我们的目标是概述目前的情况下，脑电图为基础的调查在整个欧洲。向欧洲参考网络（ERN EpiCARE）内的罕见和复杂癫痫中心分发了一份基于网络的调查。回复于2020年4月9日至5月15日收集。使用Microsoft Excel、Python Pandas和SciPy分析结果。来自22个国家的47个EpiCARE中心的代表完成了调查。在完成调查时，大多数中心的住院患者视频脑电图已被停止或限制（成人为61.7%对36.2%，儿童为38.3%对53.2%）。侵入性检查和癫痫手术同样受到影响。继续进行急性脑电图检查，而门诊脑电图检查的适应症有限，并实施了COVID-19分流。措施的严格程度因特定国家疫情的程度而异。结果表明，COVID-19对神经生理学诊断产生了深远的影响，特别是住院视频脑电图、侵入性检查和癫痫手术。2019冠状病毒病大流行可能会妨碍对需要进行脑电图检查的患者的护理，特别是癫痫患者。ERN EpiCARE将就如何快速适应这种情况提出建议，以减轻对患者的影响。
Aims. The coronavirus SARS-CoV-2 disease (COVID-19) pandemic affects availability and performance of neurophysiological diagnostic methods, including EEG. Our objective was to outline the current situation regarding EEG-based investigations across Europe.Methods. A web-based survey was distributed to centres within the European Reference Network on rare and complex epilepsies (ERN EpiCARE). Responses were collected between April 9 and May 15, 2020. Results were analysed with Microsoft Excel, Python Pandas and SciPy.Results. Representants from 47 EpiCARE centres from 22 countries completed the survey. At the time of completing the survey, inpatient video-EEGs had been stopped or restricted in most centres (61.7% vs. 36.2% for adults, and 38.3% vs. 53.2% for children). Invasive investigations and epilepsy surgery were similarly affected. Acute EEGs continued to be performed, while indications for outpatient EEGs were limited and COVID-19 triage put in place. The strictness of measures varied according to extent of the outbreak in a given country.Conclusions. The results indicate a profound impact of COVID-19 on neurophysiological diagnostics, especially inpatient video-EEGs, invasive investigations, and epilepsy surgery. The COVID-19 pandemic may hamper care for patients in need of EEG-based investigations, particularly patients with seizure disorders. ERN EpiCARE will work on recommendations on how to rapidly adapt to such situations in order to alleviate consequences for our patients.